Lipids & Metabolic

UnitedHealthcare partnered with Medtronic Feb. 1 to make the device company’s MiniMed 670G insulin pump system its preferred pump for diabetics aged 7 and up—a move the Juvenile Diabetes Research Foundation (JDRF) calls “an unacceptable step backward” and says effectively limits patients’ choices to one product.

Fast-acting, inhalable insulin is growing in popularity among American adults with diabetes, local Minnesota outlet Fox 9 reported Feb. 1.

Statin therapy reduces the risk of major cardiovascular events across all age ranges, even among people older than 75, according to a meta-analysis published in The Lancet.

A new study in JAMA Cardiology found the most avid exercisers—averaging eight hours per week of vigorous exercise—showed greater levels of coronary artery calcium (CAC). Nevertheless, they were less prone to dying over the average follow-up of 10.4 years compared to participants who exercised less, suggesting they can safely continue their workout regimens. 

A health plan-wide intervention to switch diabetic patients from costly new insulin products to older, more affordable drugs resulted in a marginal increase in hemoglobin A1c (hbA1c) levels but didn’t change the rate of hospital visits for dangerously high or low blood sugar, researchers reported Jan. 29 in JAMA.

The blood sugar drug dapagliflozin was declared noninferior to placebo in the recent DECLARE-TIMI 58 trial, and while the medication failed to lower rates of major adverse cardiovascular events (MACE) in subjects, it did reduce rates of CV-related death and hospitalizations for heart failure.

Although the 2013 American College of Cardiology and American Heart Association cholesterol guidelines expanded indications for statin use in heart patients, few primary care providers (PCPs) are prescribing more of the medication, researchers reported Jan. 25 in the Journal of the American Heart Association. 

Certain personality traits—namely hostility, negativity and low optimism—might elevate people’s risk of developing diabetes, according to research published Jan. 21 in the online journal Menopause.

Just 21 percent of adults and 17 percent of children and adolescents living with type 1 diabetes (T1D) meet the treatment goals outlined by the American Diabetes Association, according to a study published Jan. 18 in Diabetes Technology & Therapeutics.

The average annual cost of managing type 1 diabetes has skyrocketed, with the rising cost of insulin being a main contributor, according to a new issue brief from the Health Care Cost Institute.

An advisory panel to the FDA voted 8-8 Jan. 17 on a motion to approve the type 1 diabetes drug sotagliflozin, Reuters reported.

Trained “glycemia alert dogs” are more reliable in signaling out-of-range (OOR) blood sugar levels to their owners with type 1 diabetes than previously reported, according to a new study published in PLOS One.